150 related articles for article (PubMed ID: 17044464)
1. Effectiveness of oral route isosorbide 5-mononitrate on peritoneal solute and fluid transports in CAPD patients.
Kanjanabuch T; Eiam-Ong S
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S129-37. PubMed ID: 17044464
[TBL] [Abstract][Full Text] [Related]
2. Effect of amino acid based dialysate on peritoneal blood flow and permeability in stable CAPD patients: a potential role for nitric oxide?
Douma CE; de Waart DR; Struijk DG; Krediet RT
Clin Nephrol; 1996 May; 45(5):295-302. PubMed ID: 8738660
[TBL] [Abstract][Full Text] [Related]
3. The nitric oxide donor nitroprusside intraperitoneally affects peritoneal permeability in CAPD.
Douma CE; de Waart DR; Struijk DG; Krediet RT
Kidney Int; 1997 Jun; 51(6):1885-92. PubMed ID: 9186879
[TBL] [Abstract][Full Text] [Related]
4. Icodextrin with nitroprusside increases ultrafiltration and peritoneal transport during long CAPD dwells.
Douma CE; Hiralall JK; de Waart DR; Struijk DG; Krediet RT
Kidney Int; 1998 Apr; 53(4):1014-21. PubMed ID: 9551412
[TBL] [Abstract][Full Text] [Related]
5. Preserved endothelial function after long-term eccentric isosorbide mononitrate despite moderate nitrate tolerance.
Müller S; Laber U; Müllenheim J; Meyer W; Kojda G
J Am Coll Cardiol; 2003 Jun; 41(11):1994-2000. PubMed ID: 12798571
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin inhibition by intraperitoneal indomethacin has no effect on peritoneal permeability during stable CAPD.
Douma CE; de Waart DR; Zemel D; Struijk DG; Krediet RT
Nephrol Dial Transplant; 2001 Apr; 16(4):803-8. PubMed ID: 11274278
[TBL] [Abstract][Full Text] [Related]
7. Substrate and inhibitor for nitric oxide synthase during peritoneal dialysis in rabbits.
Douma CE; Zweers MM; de Waart DR; van der Wardt AB; Krediet RT; Struijk DG
Perit Dial Int; 1999; 19 Suppl 2():S358-64. PubMed ID: 10406547
[TBL] [Abstract][Full Text] [Related]
8. Single-dose effects of isosorbide mononitrate alone or in combination with losartan on central blood pressure.
Kaufman R; Nunes I; Bolognese JA; Miller DL; Salotti D; McCarthy JM; Smith WB; Herman GA; Feig PU
J Am Soc Hypertens; 2010; 4(6):311-8. PubMed ID: 21130977
[TBL] [Abstract][Full Text] [Related]
9. Isosorbide mononitrate 30% immediate-release 70% sustained-release formulation: a review. DUMQOL (DUtch Mononitrate Quality of Life) Study Group.
Cleophas TJ; Niemeyer MG; Zwinderman AH; van der Wall EE
Angiology; 2000 Aug; 51(8):631-8. PubMed ID: 10959515
[TBL] [Abstract][Full Text] [Related]
10. Clinical potential of combined organic nitrate and phosphodiesterase type 5 inhibitor in treatment-resistant hypertension.
Oliver JJ; Hughes VE; Dear JW; Webb DJ
Hypertension; 2010 Jul; 56(1):62-7. PubMed ID: 20479335
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of isosorbide-5-mononitrate after oral administration of an extended-release mononitrate formulation versus a standard dinitrate formulation.
Kosoglou T; Patrick JE; Cohen A; Radwanski E; Christopher D; Affrime MB
Clin Ther; 1995; 17(2):241-51. PubMed ID: 7614524
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide donor isosorbide mononitrate for pre-induction cervical ripening at 41 weeks' gestation: A randomized controlled trial.
Rameez MF; Goonewardene IM
J Obstet Gynaecol Res; 2007 Aug; 33(4):452-6. PubMed ID: 17688611
[TBL] [Abstract][Full Text] [Related]
13. Low doses of isosorbide mononitrate attenuate the postprandial increase in portal pressure in patients with cirrhosis.
Bellis L; Berzigotti A; Abraldes JG; Moitinho E; García-Pagán JC; Bosch J; Rodés J
Hepatology; 2003 Feb; 37(2):378-84. PubMed ID: 12540788
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of vascular oxidative stress in hypercholesterolemia by eccentric isosorbide mononitrate.
Müller S; König I; Meyer W; Kojda G
J Am Coll Cardiol; 2004 Aug; 44(3):624-31. PubMed ID: 15358031
[TBL] [Abstract][Full Text] [Related]
15. Aqueous humour flow after a single oral dose of isosorbide-5-mononitrate in healthy volunteers.
Kotikoski H; Oksala O; Vapaatalo H; Aine E
Acta Ophthalmol Scand; 2003 Aug; 81(4):355-60. PubMed ID: 12859262
[TBL] [Abstract][Full Text] [Related]
16. Impact of fill volume on peritoneal clearances and cytokine appearance in peritoneal dialysis.
Paniagua R; Ventura Mde J; Rodríguez E; Sil J; Galindo T; Hurtado ME; Alcántara G; Chimalpopoca A; González I; Sanjurjo A; Barrón L; Amato D; Mujais S
Perit Dial Int; 2004; 24(2):156-62. PubMed ID: 15119636
[TBL] [Abstract][Full Text] [Related]
17. The effect of angiotensin II receptor blocker on peritoneal membrane transports in continuous ambulatory peritoneal dialysis patients.
Jearnsujitwimol V; Eiam-Ong S; Kanjanabuch T; Wathanavaha A; Pansin P
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S188-95. PubMed ID: 17044472
[TBL] [Abstract][Full Text] [Related]
18. [Effects of nitroprusside and vibration on peritoneal transport of solutes in continuous ambulatory peritoneal dialysis patients].
Tan XY; Liu FY; Duan SB
Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):357-60. PubMed ID: 12206001
[TBL] [Abstract][Full Text] [Related]
19. Kinetics and dosing predictions for daily haemofiltration.
Leypoldt JK; Jaber BL; Lysaght MJ; McCarthy JT; Moran J
Nephrol Dial Transplant; 2003 Apr; 18(4):769-76. PubMed ID: 12637647
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of two different doses of vaginal isosorbide mononitrate in pre induction cervical ripening: a double blind randomised controlled trial.
Vidanagamage RS; Goonewardene IM
Ceylon Med J; 2011 Sep; 56(3):91-100. PubMed ID: 22164745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
